- Trials with a EudraCT protocol (7)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (12)
7 result(s) found for: Cefuroxime axetil.
Displaying page 1 of 1.
EudraCT Number: 2004-001412-30 | Sponsor Protocol Number: HMR3647A/4020 | Start Date*: 2005-12-02 |
Sponsor Name:Laboratoire Aventis | ||
Full Title: An open-label, randomized, multicenter, clinical study to compare the effects of telithromycin, azithromycin and cefuroxime axetil on the penicillin or macrolide resistance of Streptococcus pneumon... | ||
Medical condition: Patients with acute exacerbation of chronic bronchitis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-004151-35 | Sponsor Protocol Number: PK-1 | Start Date*: Information not available in EudraCT |
Sponsor Name:Universität Heidelberg | ||
Full Title: Pharmacokinetics of oral cefuroxime-axetil compared to intravenous cefuroxime in term neonates and possible adjustment of the oral therapy | ||
Medical condition: 12 Patients (full term neonates with 7 to 28 days of age) with infections of the skin, the nails or the respiratory tract. | ||
Disease: | ||
Population Age: Newborns, Under 18 | Gender: Male, Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2004-000738-34 | Sponsor Protocol Number: HMR3647B/3001 | Start Date*: 2005-09-20 | |||||||||||
Sponsor Name:Aventis Pharmaceuticals, Inc. | |||||||||||||
Full Title: Multinational, randomized, double-blind, double-dummy, comparative study to evaluate the efficacy and safety of telithromycin 25 mg/kg given once daily for 5 or 10 days depending on age and previou... | |||||||||||||
Medical condition: Acute otitis media in children. | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-000835-84 | Sponsor Protocol Number: 30982081-CAP-3001 | Start Date*: 2006-10-10 | |||||||||||
Sponsor Name:Jansen-Cilag International N.V. | |||||||||||||
Full Title: Randomized, Double-Blind, Multicenter Study of Ceftobiprole Medocaril Versus Ceftriaxone with/without Linezolid in Treatment of Subjects Hospitalized With Community-Acquired Pneumonia | |||||||||||||
Medical condition: Hospitalized community acquired pneumonia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) LT (Completed) HU (Completed) CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-004219-19 | Sponsor Protocol Number: SIMPLIFY | Start Date*: 2016-03-18 | |||||||||||
Sponsor Name:FISEVI | |||||||||||||
Full Title: Randomized, multicenter, open, phase III, controlled clinical trial, to demonstrate the non-inferiority of reduced antibiotic treatment directed against the treatment of a broad spectrum betalactam... | |||||||||||||
Medical condition: Monomicrobial bacteremia from any source due to Enterobactericiae | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-003282-17 | Sponsor Protocol Number: 190801 | Start Date*: 2020-02-11 | |||||||||||
Sponsor Name:Thomas Benfield | |||||||||||||
Full Title: Short course antibiotic treatment of Gram-negative bacteremia: A multicenter, randomized, non-blinded, non-inferiority interventional study | |||||||||||||
Medical condition: Gram-negative bacteremia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-000338-20 | Sponsor Protocol Number: MK-7655A-021 | Start Date*: 2019-06-26 | |||||||||||
Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. | |||||||||||||
Full Title: A Phase 2/3 Open-label, Randomized, Active-controlled Clinical Study to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of MK-7655A in Pediatric Participants From Birth to Less Tha... | |||||||||||||
Medical condition: Treatment of bacterial infections in pediatric populations | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) PL (Completed) Outside EU/EEA ES (Completed) BG (Completed) GR (Completed) NO (Completed) EE (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
